Primary Biliary Cholangitis Market Report 2026
Download Free Sample Buy Now
Primary Biliary Cholangitis Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Primary Biliary Cholangitis Market Report 2026

Global Outlook – By Treatment Type (Drugs, Liver Transplantation), By Diagnosis (Imaging Tests, Magnetic Resonance Elastography (MRE), Magnetic Resonance Cholangiopancreatography (MRCP), Ultrasound, Fibroscan, Blood Tests, Cholesterol Test, Antibody Tests, Liver Tests, Other Diagnoses), By End-Users (Specialty Clinics, Homecare, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Primary Biliary Cholangitis Market Overview

• Primary Biliary Cholangitis market size has reached to $1.06 billion in 2025

• Expected to grow to $1.6 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%

• Growth Driver: Surge In Liver Cancer Cases Fuels Growth In Primary Biliary Cholangitis Market

• Market Trend: Innovative Orphan Drug Combinations Transforming the Landscape of Primary Biliary Cholangitis (PBC) Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Primary Biliary Cholangitis Market?

Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by the progressive inflammation and destruction of the small bile ducts within the liver. This condition can lead to impaired bile flow, liver damage, and various related complications. PBC primarily affects middle-aged women and is often associated with symptoms such as fatigue, itching, and abdominal discomfort.

The main types of treatment for primary biliary cholangitis are drugs and liver transplantation. A drug is any chemical substance that causes a change in an organism's physiology or psychology when consumed, and ursodeoxycholic acid (UDCA) is the standard first-line treatment for PBC, which helps improve liver function, reduce liver inflammation, and slow down disease progression. Primary biliary cholangitis is diagnosed through imaging tests such as magnetic resonance elastography (MRE), magnetic resonance cholangiopancreatography (MRCP), ultrasound, fibroscan, blood tests, cholesterol tests, antibody tests, liver tests, and others by end users such as specialty clinics, homecare, and others.

Primary Biliary Cholangitis Market Global Report 2026 Market Report bar graph

What Is The Primary Biliary Cholangitis Market Size and Share 2026?

The primary biliary cholangitis market size has grown strongly in recent years. It will grow from $1.06 billion in 2025 to $1.15 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to improved understanding of autoimmune liver diseases, increased availability of diagnostic testing, expansion of specialty liver clinics, rising clinical awareness of pbc symptoms, development of standard pharmacological treatments.

What Is The Primary Biliary Cholangitis Market Growth Forecast?

The primary biliary cholangitis market size is expected to see strong growth in the next few years. It will grow to $1.6 billion in 2030 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be attributed to increasing investments in rare disease research, rising adoption of personalized medicine approaches, expansion of advanced imaging diagnostics, growing pipeline of targeted therapies, increasing focus on early-stage disease management. Major trends in the forecast period include increasing focus on targeted drug therapies, rising adoption of advanced diagnostic imaging techniques, growing integration of biomarker-based disease monitoring, expansion of personalized treatment approaches, enhanced emphasis on early disease detection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Primary Biliary Cholangitis Market Segmentation

1) By Treatment Type: Drugs, Liver Transplantation

2) By Diagnosis: Imaging Tests, Magnetic Resonance Elastography (MRE), Magnetic Resonance Cholangiopancreatography (MRCP), Ultrasound, Fibroscan, Blood Tests, Cholesterol Test, Antibody Tests, Liver Tests, Other Diagnoses

3) By End-Users: Specialty Clinics, Homecare, Other End-Users

Subsegments:

1) By Drugs: Ursodeoxycholic Acid (UDCA), Obeticholic Acid (OCA), Fibrates, Immunosuppressive Drugs, Other Targeted Therapies

2) By Liver Transplantation: Orthotopic Liver Transplantation (OLT), Living Donor Liver Transplantation, Hepatobiliary Surgery For Liver Transplant

What Is The Driver Of The Primary Biliary Cholangitis Market?

The surge in liver cancer is expected to propel the growth of the primary biliary cholangitis market going forward. Liver cancer, also known is a type of cancer that begins in the cells of the liver. The role of primary biliary cholangitis in liver cancer is significant due to the increased risk of various malignancies, including cholangiocarcinoma and hepatocellular carcinoma. The growing prevalence of the disease and its potential complications contribute to the growth of the primary biliary cholangitis market. For instance, in January 2024, the American Cancer Society, a leading professional organization in the U.S., projected approximately 41,630 new cases of liver cancer in the country, with 28,000 cases in men and 13,630 in women. Additionally, about 29,840 individuals (19,120 men and 10,720 women) are expected to succumb to this disease. Therefore, the surge in liver cancer is driving the growth of the primary biliary cholangitis industry.

Key Players In The Global Primary Biliary Cholangitis Market

Major companies operating in the primary biliary cholangitis market are Pfizer Inc, F Hoffmann La Roche Ltd, Merck And Co Inc, Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Dr Reddys Laboratories Ltd, Amneal Pharmaceuticals LLC, Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, Intercept Pharmaceuticals Inc, Arrowhead Pharmaceuticals Inc, Calliditas Therapeutics AB, NGM Biopharmaceuticals Inc, Albireo Pharma Inc, Genfit SA, CymaBay Therapeutics Inc, Ascletis Pharma Inc, Ipsen Pharma, Ferring Pharmaceuticals

Global Primary Biliary Cholangitis Market Trends and Insights

Major companies operating in the primary biliary cholangitis market are focused on developing innovative and specialized treatments, such as orphan drugs with a combination of obeticholic acid (OCA) and bezafibrates to treat primary biliary cholangitis (PBC), to gain market exclusivity. The combination of OCA and bezafibrate with an orphan drug designation aims to offer a more comprehensive and effective approach to managing PBC treatment, potentially improving the quality of life for individuals affected by this rare condition. For instance, in May 2023, Intercept Pharmaceuticals, Inc., a US-based biopharmaceutical company, received orphan drug designation from the FDA for the combination of obeticholic acid (OCA) and bezafibrate, a PPAR agonist, as a potential treatment for primary biliary cholangitis (PBC), a progressive liver disease, and obeticholic acid (marketed as Ocaliva) is approved for PBC in the US.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Primary Biliary Cholangitis Market?

In March 2023, Ipsen SA, a France-based pharmaceutical company, acquired Albireo Pharma, Inc. for an undisclosed sum. With this acquisition, Ipsen aims to expand its rare disease portfolio with novel pipeline prospects, promising therapies for rare cholestatic liver illnesses in both children and adults, and strong scientific and commercial capabilities. Albireo Pharma Inc. is a US-based biopharmaceutical company developing A3907 therapy for primary biliary cholangitis (PBC).

Regional Outlook

North America was the largest region in the primary biliary cholangitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Primary Biliary Cholangitis Market?

The primary biliary cholangitis market includes revenues earned by entities by providing services such as psychosocial support services, nutritional guidance services, medical diagnosis, and specialized medical care services. The market value includes the value of related goods sold by the service provider or included within the service offering. The primary biliary cholangitis market also includes sales of products such as fat-soluble vitamins, anti-itch medications, and imaging equipment. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Primary Biliary Cholangitis Market Report 2026?

The primary biliary cholangitis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the primary biliary cholangitis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Primary Biliary Cholangitis Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $1.15 billion
Revenue Forecast In 2035 $1.6 billion
Growth Rate CAGR of 8.4% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Treatment Type, Diagnosis, End-Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc, F Hoffmann La Roche Ltd, Merck And Co Inc, Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Dr Reddys Laboratories Ltd, Amneal Pharmaceuticals LLC, Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, Intercept Pharmaceuticals Inc, Arrowhead Pharmaceuticals Inc, Calliditas Therapeutics AB, NGM Biopharmaceuticals Inc, Albireo Pharma Inc, Genfit SA, CymaBay Therapeutics Inc, Ascletis Pharma Inc, Ipsen Pharma, Ferring Pharmaceuticals
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Primary Biliary Cholangitis Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Primary Biliary Cholangitis Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Primary Biliary Cholangitis Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Primary Biliary Cholangitis Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Focus On Targeted Drug Therapies

4.2.2 Rising Adoption Of Advanced Diagnostic Imaging Techniques

4.2.3 Growing Integration Of Biomarker-Based Disease Monitoring

4.2.4 Expansion Of Personalized Treatment Approaches

4.2.5 Enhanced Emphasis On Early Disease Detection

5. Primary Biliary Cholangitis Market Analysis Of End Use Industries

5.1 Specialty Clinics

5.2 Hospitals

5.3 Diagnostic Centers

5.4 Homecare Providers

5.5 Research Institutes

6. Primary Biliary Cholangitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Primary Biliary Cholangitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Primary Biliary Cholangitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Primary Biliary Cholangitis Market Size, Comparisons And Growth Rate Analysis

7.3. Global Primary Biliary Cholangitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Primary Biliary Cholangitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Primary Biliary Cholangitis Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Primary Biliary Cholangitis Market Segmentation

9.1. Global Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Drugs, Liver Transplantation

9.2. Global Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Imaging Tests, Magnetic Resonance Elastography (MRE), Magnetic Resonance Cholangiopancreatography (MRCP), Ultrasound, Fibroscan, Blood Tests, Cholesterol Test, Antibody Tests, Liver Tests, Other Diagnoses

9.3. Global Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Specialty Clinics, Homecare, Other End-Users

9.4. Global Primary Biliary Cholangitis Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Ursodeoxycholic Acid (UDCA), Obeticholic Acid (OCA), Fibrates, Immunosuppressive Drugs, Other Targeted Therapies

9.5. Global Primary Biliary Cholangitis Market, Sub-Segmentation Of Liver Transplantation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Orthotopic Liver Transplantation (OLT), Living Donor Liver Transplantation, Hepatobiliary Surgery For Liver Transplant

10. Primary Biliary Cholangitis Market Regional And Country Analysis

10.1. Global Primary Biliary Cholangitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Primary Biliary Cholangitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Primary Biliary Cholangitis Market

11.1. Asia-Pacific Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Primary Biliary Cholangitis Market

12.1. China Primary Biliary Cholangitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Primary Biliary Cholangitis Market

13.1. India Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Primary Biliary Cholangitis Market

14.1. Japan Primary Biliary Cholangitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Primary Biliary Cholangitis Market

15.1. Australia Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Primary Biliary Cholangitis Market

16.1. Indonesia Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Primary Biliary Cholangitis Market

17.1. South Korea Primary Biliary Cholangitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Primary Biliary Cholangitis Market

18.1. Taiwan Primary Biliary Cholangitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Primary Biliary Cholangitis Market

19.1. South East Asia Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Primary Biliary Cholangitis Market

20.1. Western Europe Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Primary Biliary Cholangitis Market

21.1. UK Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Primary Biliary Cholangitis Market

22.1. Germany Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Primary Biliary Cholangitis Market

23.1. France Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Primary Biliary Cholangitis Market

24.1. Italy Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Primary Biliary Cholangitis Market

25.1. Spain Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Primary Biliary Cholangitis Market

26.1. Eastern Europe Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Primary Biliary Cholangitis Market

27.1. Russia Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Primary Biliary Cholangitis Market

28.1. North America Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Primary Biliary Cholangitis Market

29.1. USA Primary Biliary Cholangitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Primary Biliary Cholangitis Market

30.1. Canada Primary Biliary Cholangitis Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Primary Biliary Cholangitis Market

31.1. South America Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Primary Biliary Cholangitis Market

32.1. Brazil Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Primary Biliary Cholangitis Market

33.1. Middle East Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Primary Biliary Cholangitis Market

34.1. Africa Primary Biliary Cholangitis Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Segmentation By Diagnosis, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Primary Biliary Cholangitis Market Regulatory and Investment Landscape

36. Primary Biliary Cholangitis Market Competitive Landscape And Company Profiles

36.1. Primary Biliary Cholangitis Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Primary Biliary Cholangitis Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Primary Biliary Cholangitis Market Company Profiles

36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. F Hoffmann La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck And Co Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bristol Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis

37. Primary Biliary Cholangitis Market Other Major And Innovative Companies

GlaxoSmithKline plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Dr Reddys Laboratories Ltd, Amneal Pharmaceuticals LLC, Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, Intercept Pharmaceuticals Inc, Arrowhead Pharmaceuticals Inc, Calliditas Therapeutics AB, NGM Biopharmaceuticals Inc, Albireo Pharma Inc, Genfit SA, CymaBay Therapeutics Inc

38. Global Primary Biliary Cholangitis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Primary Biliary Cholangitis Market

40. Primary Biliary Cholangitis Market High Potential Countries, Segments and Strategies

40.1 Primary Biliary Cholangitis Market In 2030 - Countries Offering Most New Opportunities

40.2 Primary Biliary Cholangitis Market In 2030 - Segments Offering Most New Opportunities

40.3 Primary Biliary Cholangitis Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Primary Biliary Cholangitis Market, Overview Of Key Products - Product Examples
  • Table 2: Global Primary Biliary Cholangitis Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Primary Biliary Cholangitis Market, Supply Chain Analysis
  • Table 4: Global Primary Biliary Cholangitis Market, Major Raw Material Providers
  • Table 5: Global Primary Biliary Cholangitis Market, Major Resource Providers
  • Table 6: Global Primary Biliary Cholangitis Market, Major Manufacturers (Suppliers)
  • Table 7: Global Primary Biliary Cholangitis Market, Major Distributors And Channel Partners
  • Table 8: Global Primary Biliary Cholangitis Market, Key Technologies & Future Trends
  • Table 9: Global Primary Biliary Cholangitis Market, Major Trends
  • Table 10: Global Primary Biliary Cholangitis Market, Major End Users
  • Table 11: Global Primary Biliary Cholangitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Primary Biliary Cholangitis Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Primary Biliary Cholangitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Primary Biliary Cholangitis Market - TAM, US$ Billion, 2025
  • Table 15: Global Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Primary Biliary Cholangitis Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Primary Biliary Cholangitis Market, Sub-Segmentation Of Liver Transplantation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Primary Biliary Cholangitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Primary Biliary Cholangitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Asia-Pacific, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: China, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: India, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: Japan, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Australia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Indonesia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: South Korea, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Taiwan, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South East Asia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Western Europe, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: UK, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Germany, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: France, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Italy, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Spain, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Eastern Europe, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Russia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: North America, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: USA, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: Canada, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: South America, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Brazil, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Middle East, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Africa, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Global Primary Biliary Cholangitis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 95: Global Primary Biliary Cholangitis Market - Company Scoring Matrix
  • Table 96: Pfizer Inc Financial Performance
  • Table 97: F Hoffmann La Roche Ltd Financial Performance
  • Table 98: Merck And Co Inc Financial Performance
  • Table 99: Novartis AG Financial Performance
  • Table 100: Bristol Myers Squibb Company Financial Performance
  • Table 101: Global Primary Biliary Cholangitis Market, Competitive Benchmarking (In USD Billions)
  • Table 102: Global Primary Biliary Cholangitis Market, Competitive Dashboard
  • Table 103: Global Primary Biliary Cholangitis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 104: Global, Primary Biliary Cholangitis Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Table 105: Global, Primary Biliary Cholangitis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Table 106: Global, Primary Biliary Cholangitis Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

List Of Figures

    Figure 1: Global Primary Biliary Cholangitis Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Primary Biliary Cholangitis Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Primary Biliary Cholangitis Market, Supply Chain Analysis
  • Figure 4: Global Primary Biliary Cholangitis Market, Major Raw Material Providers
  • Figure 5: Global Primary Biliary Cholangitis Market, Major Resource Providers
  • Figure 6: Global Primary Biliary Cholangitis Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Primary Biliary Cholangitis Market, Major Distributors And Channel Partners
  • Figure 8: Global Primary Biliary Cholangitis Market, Key Technologies & Future Trends
  • Figure 9: Global Primary Biliary Cholangitis Market, Major Trends
  • Figure 10: Global Primary Biliary Cholangitis Market, Major End Users
  • Figure 11: Global Primary Biliary Cholangitis Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Primary Biliary Cholangitis Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Primary Biliary Cholangitis Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Primary Biliary Cholangitis Market - TAM, US$ Billion, 2025
  • Figure 15: Global Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Primary Biliary Cholangitis Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Primary Biliary Cholangitis Market, Sub-Segmentation Of Liver Transplantation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Primary Biliary Cholangitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Primary Biliary Cholangitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Asia-Pacific, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: China, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: India, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: Japan, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Australia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Indonesia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: South Korea, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Taiwan, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South East Asia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Western Europe, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: UK, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Germany, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: France, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Italy, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Spain, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Eastern Europe, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Russia, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: North America, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: USA, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: Canada, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: South America, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Brazil, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Middle East, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Africa, Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Primary Biliary Cholangitis Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Global Primary Biliary Cholangitis Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 95: Global Primary Biliary Cholangitis Market - Company Scoring Matrix
  • Figure 96: Pfizer Inc Financial Performance
  • Figure 97: F Hoffmann La Roche Ltd Financial Performance
  • Figure 98: Merck And Co Inc Financial Performance
  • Figure 99: Novartis AG Financial Performance
  • Figure 100: Bristol Myers Squibb Company Financial Performance
  • Figure 101: Global Primary Biliary Cholangitis Market, Competitive Benchmarking (In USD Billions)
  • Figure 102: Global Primary Biliary Cholangitis Market, Competitive Dashboard
  • Figure 103: Global Primary Biliary Cholangitis Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 104: Global, Primary Biliary Cholangitis Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030
  • Figure 105: Global, Primary Biliary Cholangitis Market Size Gain ($ Billion), Segmentation By Diagnosis, 2025 – 2030
  • Figure 106: Global, Primary Biliary Cholangitis Market Size Gain ($ Billion), Segmentation By End-Users, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

Read More About Strategic Report on Gender Reassignment Surgery Market: Growth Opportunities and Emerging Challenges

In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Read More About In-Depth Health Check-Up Market Report: Business Trends, Growth Factors, and Forecast to 2029

Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

Read More About Global Insights: Healthcare Digital Experience Platform Market Expected to Surpass $4.34 Billion by 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Read More About Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Primary Biliary Cholangitis Market Report 2026 - Global Outlook – By Treatment Type (Drugs, Liver Transplantation), By Diagnosis (Imaging Tests, Magnetic Resonance Elastography (MRE), Magnetic Resonance Cholangiopancreat...

Diverticulitis Disease Market Report 2026 - Global Outlook – By Type (Uncomplicated, Complicated), By Diagnosis (Computed Tomography (Ct) Scan, Ultrasound, Urine Test, Blood Test), By Treatment (Medications, Surgery, Sup...

Bilirubin Blood Test Market Report 2026 - Global Outlook – By Test Type (Total Serum Bilirubin Test, Indirect Or Unconjugated Bilirubin Test, Direct Or Conjugated Bilirubin Test), By Age Group (Adults, Pediatrics, Infant...

Hepatic Encephalopathy Market Report 2026 - Global Outlook – By Drug Class (Antibiotics, Laxatives), By Route Of Administration (Oral, Intravenous, Rectal ), By Distribution Channel (Hospital Pharmacies, Retail Pharmacie...

Non-Alcoholic Steatohepatitis Treatment Market Report 2026 - Global Outlook – By Drug Type (Vitamin E And Pioglitazone, Ocaliva, Elafibranor, Selonsertib And cenicriviroc, Obeticholic Acid, Other Drugs Types), By Test Ty...

Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Report 2026 - Global Outlook – By Product (Electrosurgery Instruments, Endoscope, Hand Instruments, Access Instruments, Stents, Energy/Vessel Sealing Dev...

Ear Infection Market Report 2026 - Global Outlook – By Type (Middle Ear, Outer Ear, Inner Ear), By Pathogen (Bacteria, Virus), By Treatment Type (Medication, Antibiotics, Analgesics, Antiviral, Surgery, Other Treatment T...

Viral Gastroenteritis Market Report 2026 - Global Outlook – By Drugs (Antibiotics, Antacids, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdo...

Frequently Asked Questions

The Primary Biliary Cholangitis Market Report 2026 market was valued at $1.06 billion in 2025, increased to $1.15 billion in 2026, and is projected to reach $1.6 billion by 2030. request a sample here

The expected CAGR for the Primary Biliary Cholangitis Market Report 2026 market during the forecast period 2025–2030 is 8.7%. request a sample here

Major growth driver of the market includes: Surge In Liver Cancer Cases Fuels Growth In Primary Biliary Cholangitis Market in the Primary Biliary Cholangitis Market Report 2026 market. For further insights on this market, request a sample here

The primary biliary cholangitis market covered in this report is segmented –
1) By Treatment Type: Drugs, Liver Transplantation
2) By Diagnosis: Imaging Tests, Magnetic Resonance Elastography (MRE), Magnetic Resonance Cholangiopancreatography (MRCP), Ultrasound, Fibroscan, Blood Tests, Cholesterol Test, Antibody Tests, Liver Tests, Other Diagnoses
3) By End-Users: Specialty Clinics, Homecare, Other End-Users Subsegments:
1) By Drugs: Ursodeoxycholic Acid (UDCA), Obeticholic Acid (OCA), Fibrates, Immunosuppressive Drugs, Other Targeted Therapies
2) By Liver Transplantation: Orthotopic Liver Transplantation (OLT), Living Donor Liver Transplantation, Hepatobiliary Surgery For Liver Transplant request a sample here

Major trend in this market includes: Innovative Orphan Drug Combinations Transforming the Landscape of Primary Biliary Cholangitis (PBC) Treatment For further insights on this market, request a sample here.

Major companies operating in the Primary Biliary Cholangitis Market Report 2026 market are Major companies operating in the primary biliary cholangitis market are Pfizer Inc, F Hoffmann La Roche Ltd, Merck And Co Inc, Novartis AG, Bristol Myers Squibb Company, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Boehringer Ingelheim International GmbH, Gilead Sciences Inc, Dr Reddys Laboratories Ltd, Amneal Pharmaceuticals LLC, Alnylam Pharmaceuticals Inc, Ionis Pharmaceuticals Inc, Intercept Pharmaceuticals Inc, Arrowhead Pharmaceuticals Inc, Calliditas Therapeutics AB, NGM Biopharmaceuticals Inc, Albireo Pharma Inc, Genfit SA, CymaBay Therapeutics Inc, Ascletis Pharma Inc, Ipsen Pharma, Ferring Pharmaceuticals request a sample here.

North America was the largest region in the primary biliary cholangitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the primary biliary cholangitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us